Milk drink's anti-dementia claims a bit frothy

Although Souvenaid does have some impact on secondary endpoints

A nutritional drink, spruiked in the media as ‘putting the brakes’ on Alzheimer’s, failed to show any benefit on the primary cognitive outcome in a randomised controlled trial.

media reports on Souvenaid

The milk-like supplement Souvenaid, which contains omega 3, antioxidants and vitamins, has been widely reported as having the potential to arrest cognitive decline in people with prodromal Alzheimers disease based on new findings from a European trial.

However, media reports focused on secondary outcomes and ignored the lack of significant improvement in the trial’s primary endpoint based on